Want to see TSE:NLH full AI Analyst Report?
Nova Leap Health (NLH) Ratios
Nova Leap Health Ratios
TSE:NLH's free cash flow for Q2 2026 was $846.58K. For the 2026 fiscal year, TSE:NLH's free cash flow was increased by $4.00 and operating cash flow was $846.58K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.96 | 1.06 | 1.59 | 1.00 | 0.96 |
| Quick Ratio | 0.96 | 1.06 | 1.59 | 1.00 | 0.96 |
| Cash Ratio | 0.40 | 0.43 | 0.50 | 0.32 | 0.28 |
| Solvency Ratio | 0.15 | 0.47 | -0.19 | 0.10 | 0.32 |
| Operating Cash Flow Ratio | 0.38 | 0.43 | 1.21 | 0.26 | 0.35 |
| Short-Term Operating Cash Flow Coverage | 0.74 | 1.05 | 10.35 | 0.43 | 0.55 |
| Net Current Asset Value | $ -846.41K | $ -719.63K | $ 142.17K | $ -1.29M | $ -2.33M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.12 | 0.11 | 0.07 | 0.17 | 0.23 |
| Debt-to-Equity Ratio | 0.15 | 0.14 | 0.08 | 0.21 | 0.34 |
| Debt-to-Capital Ratio | 0.13 | 0.12 | 0.07 | 0.18 | 0.25 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.01 | 0.00 | 0.01 | 0.05 |
| Financial Leverage Ratio | 1.23 | 1.23 | 1.15 | 1.28 | 1.45 |
| Debt Service Coverage Ratio | 0.84 | 1.45 | 3.70 | 0.30 | 0.92 |
| Interest Coverage Ratio | 3.16 | 8.08 | 3.18 | -4.06 | 9.71 |
| Debt to Market Cap | 0.11 | 0.09 | 0.01 | 0.17 | 0.14 |
| Interest Debt Per Share | 0.04 | 0.03 | 0.02 | 0.05 | 0.09 |
| Net Debt to EBITDA | 0.73 | 0.45 | 0.51 | 6.41 | 0.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.03% | 38.38% | 37.31% | 35.37% | 33.89% |
| EBIT Margin | 3.51% | 7.45% | 1.76% | -3.32% | 13.51% |
| EBITDA Margin | 6.16% | 9.71% | 3.80% | 1.49% | 22.35% |
| Operating Profit Margin | 3.51% | 3.35% | 1.76% | -3.90% | 18.30% |
| Pretax Profit Margin | -0.42% | 7.03% | -5.22% | -4.28% | 11.62% |
| Net Profit Margin | -0.60% | 5.35% | -4.03% | -2.96% | 8.27% |
| Continuous Operations Profit Margin | -0.60% | 5.35% | -4.03% | -2.96% | 8.27% |
| Net Income Per EBT | 143.78% | 76.07% | 77.21% | 69.27% | 71.19% |
| EBT Per EBIT | -11.94% | 209.79% | -296.86% | 109.73% | 63.52% |
| Return on Assets (ROA) | -0.82% | 6.16% | -5.05% | -3.49% | 6.58% |
| Return on Equity (ROE) | -1.02% | 7.55% | -5.80% | -4.47% | 9.53% |
| Return on Capital Employed (ROCE) | 5.71% | 4.51% | 2.41% | -5.51% | 18.95% |
| Return on Invested Capital (ROIC) | 5.13% | 3.16% | 1.81% | -3.36% | 11.17% |
| Return on Tangible Assets | -3.30% | 23.84% | -18.40% | -12.26% | 22.05% |
| Earnings Yield | -1.09% | 8.39% | -6.01% | -5.84% | 4.91% |
| Efficiency Ratios | |||||
| Receivables Turnover | 17.46 | 15.17 | 15.85 | 16.09 | 9.80 |
| Payables Turnover | 14.69 | 10.15 | 13.95 | 15.56 | 13.98 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 35.32 | 26.38 | 22.03 | 18.88 | 16.45 |
| Asset Turnover | 1.37 | 1.15 | 1.25 | 1.18 | 0.79 |
| Working Capital Turnover Ratio | 1300.05 | 41.55 | 50.06 | -205.24 | -406.90 |
| Cash Conversion Cycle | -3.94 | -11.90 | -3.13 | -0.77 | 11.13 |
| Days of Sales Outstanding | 20.90 | 24.06 | 23.03 | 22.69 | 37.23 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 24.85 | 35.95 | 26.16 | 23.46 | 26.10 |
| Operating Cycle | 20.90 | 24.06 | 23.03 | 22.69 | 37.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 |
| Free Cash Flow Per Share | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 55.52 | 76.98 | 14.33 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 55.52 | 76.98 | 14.33 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.48 | 0.55 | 1.54 | 0.26 | 0.35 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.05 | 0.08 | 0.04 | 0.10 |
| Free Cash Flow Yield | 7.95% | 8.30% | 12.12% | 6.63% | 6.08% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -92.68 | 11.95 | -16.64 | -17.14 | 20.38 |
| Price-to-Sales (P/S) Ratio | 0.56 | 0.64 | 0.67 | 0.51 | 1.69 |
| Price-to-Book (P/B) Ratio | 0.94 | 0.90 | 0.96 | 0.77 | 1.94 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.58 | 12.05 | 8.25 | 15.08 | 16.46 |
| Price-to-Operating Cash Flow Ratio | 12.58 | 11.83 | 8.15 | 14.03 | 16.46 |
| Price-to-Earnings Growth (PEG) Ratio | 0.81 | -0.05 | -1.28 | 0.11 | 0.00 |
| Enterprise Value Multiple | 9.75 | 7.01 | 18.15 | 40.48 | 8.49 |
| Enterprise Value | 19.24M | 17.55M | 18.05M | 17.02M | 40.35M |
| EV to EBITDA | 9.75 | 7.01 | 18.15 | 40.48 | 8.49 |
| EV to Sales | 0.60 | 0.68 | 0.69 | 0.60 | 1.90 |
| EV to Free Cash Flow | 13.60 | 12.87 | 8.49 | 17.92 | 18.51 |
| EV to Operating Cash Flow | 13.60 | 12.64 | 8.38 | 16.67 | 18.51 |
| Tangible Book Value Per Share | 0.02 | 0.02 | 0.04 | 0.02 | -0.00 |
| Shareholders’ Equity Per Share | 0.22 | 0.21 | 0.21 | 0.24 | 0.25 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.44 | 0.24 | 0.23 | 0.31 | 0.29 |
| Revenue Per Share | 0.37 | 0.29 | 0.30 | 0.36 | 0.29 |
| Net Income Per Share | -0.00 | 0.02 | -0.01 | -0.01 | 0.02 |
| Tax Burden | 1.44 | 0.76 | 0.77 | 0.69 | 0.71 |
| Interest Burden | -0.12 | 0.94 | -2.97 | 1.29 | 0.86 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.33 | 0.33 | 0.32 | 0.34 | 0.36 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Income Quality | -7.45 | 1.01 | -2.04 | -1.22 | 1.24 |
Currency in USD
